Evidence map›Paper›PMID 15847642›Full record

ArticleActa physiologica Scandinavica2005

HSP20 phosphorylation and interstitial metabolites in hypoxia-induced dilation of swine coronary arteries.

O Frøbert, C L Buus, C M Rembold

Open access · greenAbstract read
In one paragraph

Article in Acta physiologica Scandinavica, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

O FrøbertDepartment of Cardiology S, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aarhus, Denmark. frobert@dadlnet.dk
C L Buus
C M Rembold
Aarhus University · DKUniversity of Virginia Health System · US

Funding

P20-Mediated Suppression of Vascular ForceR01HL071191 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI REMBOLD, CHRISTOPHER M · 2002 to 2004
$999k
NHLBI NIH HHS HL71191NHLBI NIH HHS R01 HL071191
6 · The paper itself

Abstract

objectiveHypoxia induces coronary artery dilation, but the responsible mechanism is largely unknown. Many stimuli induce arterial smooth muscle relaxation by reducing ser19-myosin regulatory light chain (MLC) phosphorylation. Other stimuli can induce smooth muscle relaxation without reductions in ser19-MLC phosphorylation. This form of relaxation has been termed force suppression and appears to be associated with heat shock protein 20 (HSP20) phosphorylation on ser16. We investigated whether hypoxia-induced sustained dilation in swine coronary arteries was promoted without ser19-MLC dephosphorylation and associated with ser16-HSP20 phosphorylation. Nitroglycerin vasodilation served as control.

methodsIn a pressure myograph, the tunica media of intact pre-contracted (PGF(2alpha); 10(-5) m) porcine coronary artery segments were cannulated using a microdialysis catheter. Diameter responses and interstitial lactate/pyruvate ratios were studied during 90 min hypoxia, hypoxia + reoxygenation (60 min), nitroglycerin (100 microm, 90 min), and nitroglycerin + wash-out (60 min). The arterial segments were snap-frozen and analysed for ser16-HSP20 phosphorylation and ser19-MLC phosphorylation.

resultsThe normalized diameter responses to hypoxia (6.1 +/- 4.3%) and nitroglycerin (12.6 +/- 1.6%) were both significantly greater than normoxic control arteries (-10.5 +/- 1.8%, anova, P < 0.05). Ser16-HSP20 phosphorylation was increased with hypoxia and nitroglycerin treatment and ser16-HSP20 phosphorylation correlated with changes in diameters (n = 29, r2 = 0.64, P < 0.001). Ser19-MLC phosphorylation was not significantly altered by hypoxia. The lactate/pyruvate ratio was significantly increased in hypoxic arteries but did not correlate with diameters or ser16-HSP20 phosphorylation.

conclusionSer16-HSP20 phosphorylation is a potential regulator of hypoxia-induced dilation in coronary arteries.

Indexed as

AnimalsBlood GlucoseCoronary VesselsDilatation, PathologicHeat-Shock ProteinsHSP20 Heat-Shock ProteinsHypoxiaLactatesMaleMuscle, Smooth, VascularMyosin Light ChainsNitroglycerinPhosphoproteinsPhosphorylationPyruvic AcidSwineBlood GlucoseHeat-Shock ProteinsHSP20 Heat-Shock ProteinsLactatesMyosin Light ChainsNitroglycerinPhosphoproteinsPyruvic AcidVasodilator Agents

Identifiers

PMID15847642
PMCPMC2276684
OpenAlexW2078300430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.